Unable to load price data. Sorry.

¯\_(ツ)_/¯

China Sky One Medical (NASDAQ OTHER:CSKI)

CAPS Rating: No stars

The company develops, manufactures, markets, and sells over-the-counter, branded nutritional supplements, and over-the-counter plant- and herb-based pharmaceuticals primarily in China.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

423 Outperform
32 Underperform
 

All-Star Players

29 Outperform
12 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top NASDAQ OTHER:CSKI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

kalouti (< 20)
Submitted September 30, 2010

This company is not a fraud. It had accounting issues in 2009 which were over inflamed by a few short investors.Slapped on the hand by the SEC it departed ways with non reporting distributors, fixed its accounting errors and learned its lesson.With… More

BuffettJunior1 (98.61)
Submitted October 28, 2011

Chinese reverse merger fraud.

NASDAQ OTHER:CSKI VS S&P 500 (SPY)

Fools bullish on NASDAQ OTHER:CSKI are also bullish on:

Fools bearish on NASDAQ OTHER:CSKI are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CSKI.

Recs

1
Member Avatar BuffettJunior1 (98.61) Submitted: 10/28/2011 3:29:22 PM : Underperform Start Price: $1.95 NASDAQ OTHER:CSKI Score: +217.33

Chinese reverse merger fraud.

Recs

0
Member Avatar tilbud (< 20) Submitted: 7/4/2011 2:26:09 PM : Outperform Start Price: $2.12 NASDAQ OTHER:CSKI Score: -208.73

CSKI has been the target of relentless short attacks that are based on wild distortions. Of course the company has some problems, as do the strongest companies in the U.S. But it also has outstanding metrics and shows great promise in extending its business beyond traditional Chinese medicines. It is a well run company and its success is sure to be recognized by institutional investors and quite possibly by international drug manufacturers seeking a cost effective entry into the vast Chinese market.

Recs

0
Member Avatar ChinaBottom (< 20) Submitted: 6/24/2011 12:01:56 AM : Outperform Start Price: $2.23 NASDAQ OTHER:CSKI Score: -217.95

Tracking portfolio for China based companies that gained listings on US exchanges (Nasdaq, NYSE, or Amex) after conducting reverse mergers. Stocks that have been delisted have been omitted. Start date: Jun 24, average P/E of these companies: 3.

Leaderboard

Find the members with the highest scoring picks in CSKI.

Score Leader

unstoppablepeon

unstoppablepeon (24.24) Score: +334.83

The Score Leader is the player with the highest score across all their picks in CSKI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
unstoppablepeon 24.24 10/27/2008 Underperform NS $6.87 -99.13% +235.71% +334.83 0 Comment
Alain988 < 20 5/4/2009 Underperform 1Y $14.67 -99.59% +222.96% +322.55 0 Comment
DavisFreeberg 95.33 5/15/2009 Underperform 5Y $14.14 -99.58% +220.61% +320.19 0 Comment
tcss007 26.17 6/12/2009 Underperform 5Y $16.76 -99.64% +202.93% +302.57 0 Comment
DrRetardles 23.52 8/17/2009 Underperform 5Y $14.93 -99.60% +188.36% +287.96 0 Comment
obsoleteaccount < 20 7/2/2010 Underperform 5Y $11.00 -99.45% +174.48% +273.94 0 Comment
Secksuality 29.20 9/14/2009 Underperform 5Y $13.55 -99.56% +173.75% +273.31 0 Comment
longtermgrowth09 24.61 7/19/2010 Underperform 5Y $9.62 -99.38% +164.38% +263.76 0 Comment
pcoppney < 20 10/13/2009 Underperform 1Y $13.88 -99.57% +163.50% +263.06 1 Comment
Infantryman11 < 20 12/2/2009 Underperform 3W $17.10 -99.65% +154.33% +253.98 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackVanDenBerg 93.77 6/10/2009 Outperform 1Y $17.60 -99.66% +199.53% -299.19 1 Comment
TrackJGreenblatt 52.04 10/14/2008 Outperform 1Y $9.79 +42.19% +3.56% +38.62 10/14/2009 @ $13.92 2 Comments

Advertisement